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Abstract
Background: Gene expression analyses are used to investigate signaling pathways involved in diseases. In asthma, they
have been primarily derived from the analysis of bronchial biopsies harvested from mild to moderate asthmatic subjects
and controls. Due to ethical considerations, there is currently limited information on the transcriptome profile of the
peripheral lung tissues in asthma.
Objective: To identify genes contributing to chronic inflammation and remodeling in the peripheral lung tissue of horses
with heaves, a naturally occurring asthma-like condition.
Methods: Eleven adult horses (6 heaves-affected and 5 controls) were studied while horses with heaves were in clinical
remission (Pasture), and during disease exacerbation induced by a 30-day natural antigen challenge during stabling
(Challenge). Large peripheral lung biopsies were obtained by thoracoscopy at both time points. Using suppression
subtractive hybridization (SSH), lung cDNAs of controls (Pasture and Challenge) and asymptomatic heaves-affected horses
(Pasture) were subtracted from cDNAs of horses with heaves in clinical exacerbation (Challenge). The differential expression
of selected genes of interest was confirmed using quantitative PCR assay.
Results: Horses with heaves, but not controls, developed airway obstruction when challenged. Nine hundred and fifty cDNA
clones isolated from the subtracted library were screened by dot blot array and 224 of those showing the most marked
expression differences were sequenced. The gene expression pattern was confirmed by quantitative PCR in 15 of 22
selected genes. Novel genes and genes with an already defined function in asthma were identified in the subtracted cDNA
library. Genes of particular interest associated with asthmatic airway inflammation and remodeling included those related to
PPP3CB/NFAT, RhoA, and LTB4/GPR44 signaling pathways.
Conclusions: Pathways representing new possible targets for anti-inflammatory and anti-remodeling therapies for asthma
were identified. The findings of genes previously associated with asthma validate this equine model for gene expression
studies.
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Introduction
Inflammation and remodeling of the airway wall are charac-
teristic features of asthma. The term ‘‘airway remodeling’’ in
bronchial asthma is used to describe the structural changes that
occur in conjunction with, or because of, chronic inflammation. A
consequence of asthmatic airway remodeling is incompletely
reversible, or even irreversible airway obstruction, bronchial
hyperresponsiveness, and an accelerated decline in lung function
[1]. Remodeling processes in asthma result from highly complex,
and poorly defined interactions between inflammatory and
resident structural cells [2]. Therefore, the identification of the
molecular pathways involved in the crosstalk between these cells is
a prerequisite for the development of novel therapy to control
airway remodeling.
Expression profile studies allow the discovery of transcripts
correlated to disease phenotype and to generate hypotheses
regarding genes and pathways underlying these phenotypic
changes. Gene expression studies using human lung tissues have
been primarily derived from the analysis of bronchial biopsies
harvested from mild to moderate asthmatic subjects and controls
[3]. These studies have identified candidate genes and pathways
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information on the transcriptome profile of the peripheral lung
tissues where remodeling predominantly occurs in non-fatal
asthma [4,5]. Using rodent models of asthma, microarrays
analyses of whole lung tissues have been used to reveal the
complex signaling pathways associated with the initiation of the
asthmatic response. However, mice have important differences in
the anatomy of the lungs compared to humans, including the
relative paucity of airway smooth muscle [6]. Furthermore,
sensitization to multiple antigens and recurrent challenges over
many years do not occur, thus making the immune response and
the crosstalk between structural cells potentially less complex than
in people.
Studies of comparative pulmonary morphology show that the
horse’s lung closely resembles the human lung [7,8] and their
lifespan (30–35 years) is closer to human than small rodents. Also,
10 to 20% of horses develop a condition called heaves that shares
many features of ‘‘extrinsic’’ human asthma, including lower
airway inflammation, reversible airflow obstruction, and bronchial
hyperresponsiveness [9,10,11]. Heaves develop spontaneously in
susceptible horses and, similarly to asthma, is associated with
increased airway smooth muscle mass, goblet cell hyperplasia, and
epithelial detachment and regeneration [12,13,14,15]. The horses
size and temperament also allow for multiple sampling from the
same animal to compare gene expression of the lung tissue under
conditions of disease exacerbation and remission. Thus, equine
heaves is an appealing model to study the complex inflammation-
induced remodeling processes present in chronic asthma.
Suppression subtractive hybridization technique (SSH) is a
highly sensitive PCR-based cDNA subtraction method [16] used
to identify differentially expressed genes, including genes of
relatively low abundances. It selectively amplifies differentially
expressed cDNA fragments while suppressing nontarget cDNA
amplification. SSH provides an approximately 1000-fold enrich-
ment of low copy number genes related to defined phenotypes
[17]. Compared to microarray analysis, SSH is more sensitive,
sequence independent and yields relatively few false positive [18].
The goal of this study was to document the transcriptome
associated with chronic asthmatic inflammation and tissue
remodeling. We use SSH to subtract the lung transcriptome
obtained from heaves-affected horses during clinical remission as
well as from control horses with or without antigen exposure from
lung cDNAs of horses with heaves after a 30-day antigen
challenge.
Materials and Methods
Experimental animal model, tissue collection, and RNA
isolation
Eleven horses (450–550 kg) including 9 mares and 2 geldings
were studied. Six horses with heaves (mean 6 SD, 16.862.14
years of age) had a history (mean duration 6.462.9 years) of
recurrent episodes of airway obstruction upon hay exposure,
abnormal respiratory mechanic measurements, and increased
neutrophils in bronchoalveolar (BAL) fluid. Control horses (n=5,
13.862.39 years of age) had no history of respiratory diseases.
Detailed description of the animals, their airway function and lung
inflammation have been reported elsewhere [15]. All experimental
procedures were performed in accordance with the Canadian
Council for Animal Care guidelines and were approved by the
Animal Care Committee of the Faculty of Veterinary Medicine of
the Universite ´ de Montre ´al (06-Rech-1324).
All animals were kept together in a low antigenic environment
(Pasture) for .3 months prior to the baseline measurements and
were then stabled in box stalls for 30 days where they were
exposed to hay and barn dust (Challenge). Large peripheral lung
biopsies were obtained at baseline and after the 30-day challenge
by thoracoscopy as reported previously [19]. Biopsies were snap
frozen in liquid nitrogen within 3 minutes and stored for a
maximum of 5 months at 280uC until RNA extraction.
Total RNA was isolated as previously described [20]. The
concentration of total RNA was quantified by measuring optical
density at 260 nm using a spectrophotometer (NanoDrop ND-
1000, NanoDrop products, Wilmington, DE, USA). The Agilent
2100 bioanalyzer (Agilent Technologies, Wilmington, DE, USA)
was used to calculate the RNA integrity number (RIN).
Suppression subtractive hybridization
SSH was used to compare gene expression in lung tissues of
symptomatic heaves-affected horses during challenge (SH) versus
heaves-affected horses at baseline and controls at both time points
(all regrouped as ‘‘Ctls’’). Identical amounts of total RNA from
each horse were pooled within SH (n=6) and Ctls (n=16) groups
to decrease inter-animal variation (Figure 1.B). The SSH
procedures were performed as previously reported [21] and are
illustrated in figure 1.A and C. In brief, double-stranded cDNA
were generated using the SMART PCR cDNA Synthesis Kit for
both SH and Ctls samples according to the manufacturer’s
instruction (user manual PT3041-1, Clontech Laboratories, Inc.,
Mountain View, CA, USA). One mg of total RNA from each
pooled groups were reverse transcribed in a total volume of 10 ul
with two primers (39 SMART
TM CDS Primer II A and SMART
II
TM A Oligonucleotide) and PowerScript reverse transcriptase
(Clontech Laboratories, Inc., Mountain View, CA, USA), with the
addition of 42 ng of T4 gene 32 protein (Roche Applied Science,
Laval, QC, CA) to produce first cDNA strand. The resulting
cDNA pools were diluted to 50 ml in TE buffer (10 mM Tris
pH 8, 1 mM EDTA). Double-stranded cDNA were obtained via
PCR amplification of 19 cycles with 59PCR Primer II A using
Advantage II DNA polymerase (Clontech Laboratories, Inc.,
Mountain View, CA, USA).
Subtracted forward (SH-Ctls) and reverse (Ctls-SH) reactions
were generated by subtracting Ctls cDNAs from SH cDNAs and
SH cDNAs from Ctls cDNAs, respectively, using the PCR-select
cDNA Subtraction Kit (user manual PT1117-1, Clontech
Laboratories, Inc., Mountain View, CA, USA). To perform the
subtraction reactions, SH and Ctls cDNAs were digested with RsaI
to obtain shorter, blunt-ended molecules suitable for adaptor
ligation and optimal for subtractive hybridization.
Subtraction efficiency was evaluated by comparing the
abundance of known genes in subtracted and unsubtracted
cDNAs population after different cycles of PCR using Advantage
II DNA polymerase (Clontech Laboratories, Inc., Mountain View,
CA, USA). Equine gene specific primers were designed for two
genes; one that is constitutively expressed, glyceraldehyde 3-
phosphate dehydrogenase (GAPDH); and lipocalin 2 (LCN2), a
gene known for its association with lung diseases [22] (Table S1).
The subtraction efficiency was indicated by the difference in the
number of cycles needed to generate equal amplification of the
corresponding PCR product before and after subtraction for these
two genes.
Cloning of subtracted cDNAs
The purified (QIAquick PCR Purification kit, Qiagen, Toronto,
ON, CA) subtracted (SH-Ctls) cDNAs were cloned into the pDrive-
cloning vector (Qiagen, Toronto, ON, CA). Ligation products were
then used to transform competent cells (DH5a, Invitrogen,
Carlsbad, CA, USA), which were spread onto S-GalHLB agar
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supplemented with kanamycin (40 mg/ml). Individual colonies
(950) were transferred into ten 96-well plates containing LB freezing
media (8.8% glycerol, 55 mM K2HPO4, 1 mM MgSO4,2 6m M
KH2PO4,1 5m MN H 4(SO4)) and incubated overnight to construct
the SH-Ctls subtracted library.
Differential hybridization screening
SH-Ctls subtracted macroarrays were established for differential
screening, as previously described [21]. Briefly, PCR amplification
was performed on the insert of each cDNA clone from the SH-Ctls
subtracted library plates using AmpliTaq DNA Polymerase
(Applied Biosystems, Foster City, CA, USA), with PCR-nested
Figure 1. Methodology for SSH. Schematic representation of the different steps described in Material and Methods (A), the sample pooling (n
corresponds to the number of samples) (B), and the different hybridization steps performed with the SSH technique (C).
doi:10.1371/journal.pone.0029440.g001
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CA, USA) for 27 cycles. PCR products from each insert were
denatured in 0.3 M NaOH colored with 5% bromophenol blue
and vacuum-transferred onto nylon membranes (Hybond-N+,
Amersham Pharmacia Biotech, Pointe-Claire, QC, CA) using a
96-well dot-blot apparatus and cross-linked to the membrane with
UV light (150 mJ, GS Gene Linker, Bio-Rad, Mississauga, ON,
CA). Positive control cDNA (LCN2) was also transferred on each
membrane. For each SH-Ctls subtracted library plates, four
identical cDNA macroarray membranes were generated.
Probes for the differential screening of macroarray membranes
were obtained from unsubtracted (SH and Ctls) and subtracted
(SH-Ctls and Ctls-SH) complex cDNA populations via secondary
nested PCR amplification (PCR-select cDNA Subtraction Kit,
Clontech Laboratories, Inc., Mountain View, CA, USA). Probes
were then purified (QIAquick PCR Purification kit, Qiagen,
Toronto, ON, CA), digested with AfaI, SmaI and EagI to remove
adaptors and purified again (QIAquick PCR Purification kit,
Qiagen, Toronto, ON, CA). One hundred nanograms of the
cDNA probes were labeled by random priming with a
32P[dCTP]
(Megaprime DNA labeling System, GE Healthcare, Buckingham-
shire, UK) as described previously [21]. Radio-labeled cDNA
probes were purified (QIAquick Nucleotide Removal Kit, Qiagen,
Toronto, ON, CA) and quantified with a liquid scintillation
analyzer (Tri-Carb 2100TR, Packard BioScience Compagny,
Meriden, CT, USA).
Each membrane was individually hybridized and washed as
describe previously [21]. SH-Ctls macroarray membrane repli-
cates were hybridized with identical amounts (cpm) of specific heat
denatured cDNA probe (SH-Ctls, Ctls-SH, SH or Ctls). Washed
membranes were exposed to a phosphor screen for 4 hours and
the images were digitized (Storm 840, GE Healthcare, Buck-
inghamshire, UK). cDNA clones with different hybridization
pattern were characterized using DNA sequencing and gene
expression analysis.
DNA sequencing and sequence analysis
The differentially expressed cDNA clones were amplified by
PCR from the PCR products generated initially for the
macroarrays using the Advantage II DNA polymerase (Clontech
Laboratories, Inc., Mountain View, CA, USA) and the PCR-
nested primers 1 and 2R. Amplicons were analyzed on 1.5%
agarose gel with ethidium bromide to detect multiple PCR
fragments. Single band amplicons were gel extracted (QIAquick
Gel Extraction kit, Qiagen, Toronto, ON, CA) and sequenced via
the dideoxy method (Big Dye Terminator 3.0, ABI Prism, Applied
Biosystem, Foster City, CA, USA) by Ge ´nome Que ´bec using the
PCR-nested primers 1 or 2R. Sequencing reactions were analyzed
with an ABI Prism 310 sequencer (Applied Biosystem, Foster City,
CA, USA). Nucleic acid sequences with at least 100 bp were
aligned against GenBank database (NR and EST) using the Basic
Local Alignment Search Tool (BLAST). The maximum expected
(E) value accepted to be considered homologous was e
230. Every
match with higher E value score was aligned against the horse
genome at the UCSC Genome Browser database using BLAT
(BLAST-like alignment tool; http://genome.ucsc.edu/). Sequenc-
es were classified into two groups: I) genes with known sequence
and function and II) genes with characterized sequence but
unknown function. The genes from the 1
st group were further
classified through biological function categories using functional
mapping tools (GeneOntology, http://www.geneontology.org/)
and compared to available literature related to human asthma and
other animal models. This classification allowed us to identify
biological pathways, gene families or biological functions likely to
be relevant to airway remodeling and, thus, to select candidate
biomarkers possibly associated with asthma.
Validation step: Gene expression analysis
Quantitative PCR (qPCR) was used to validate the differential
gene expression of 22 positive cDNA clones from the SH-Ctls
library. First strand cDNA were generated using the SMART
PCR cDNA Synthesis Kit (Clontech Laboratories, Inc., Mountain
View, CA, USA) and the SuperScript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA, USA) for each individual horse at
baseline and after challenge as described above. When possible,
equine gene-specific primers (Table S1) were designed to span at
least two intron-exon boundaries for the discrimination of
contaminant genomic DNA. The absence of nonspecific products
was confirmed by the analysis of the melting point curves and by
electrophoresis in 1.5% agarose gels. All concentrations of target
gene cDNA were calculated relatively to their respective standard
curves. One microliter of cDNA template was added to the
Quantitec SYBRHGreen PCR Kit master mix (Qiagen, Toronto,
ON, CA). qPCR reactions were performed in a volume of 20 ml
using Rotor-Gene RG-3000 (Corbett Research, Sydney, AS) and
qPCR conditions were similar for all primer sets (0.5 mM, final
concentration): denaturation 95uC for 10 min, cycling 95uC for
15 sec, 55uC for 25 sec and 72uC for 25 sec for a maximum of 40
cycles. Each reaction was run in duplicate with the appropriate
negative control. Reference gene expression was evaluated using
different analysis softwares: NormFinder [23], GeNorm
PLUS [24]
and Rest 2009 [25].
Statistical analysis
Data are presented as mean 6 SD. Differences between groups
were compared at each time point using Wilcoxon tests and
differences within groups were evaluated using Mann-Whitney
test. Unilateral tests were used to compare values with those of
asthmatic horses after 30 days of antigen challenge because SSH
technique predicted the direction of the effect. Bilateral tests were
used for all other analyses. P,0.05 was considered significant.
Results
Experimental animal model
All horses had normal lung function prior to challenge, while
only horses with heaves developed clinical signs of airway
obstruction and persistent airway inflammation after antigen
challenge (see [15] for detailed description of lung function and
BAL fluid cytology in these animals).
Identification of differentially expressed genes
The quality of the RNA samples was confirmed by high RIN
values (8.4760.58 SD) and electropherogram analysis. Subtrac-
tion efficiency was evaluated using standard PCR for two genes;
GAPDH and LCN2. GAPDH PCR products were detectable after
only 18 cycles in the SH unsubtracted sample, whereas 10 more
cycles were required to detect the PCR fragment in the SH-Ctls
subtracted sample (Figure 2.A), a 40 fold reduction. LCN2 PCR
products were detectable after 20 cycles in both subtracted SH-
Ctls and unsubtracted SH samples, but the difference in intensity
between the two signals indicates enrichment (Figure 2.B).
Conversely, the LCN2 PCR products were detected after 20 cycles
in the unsubtracted Ctls sample and after 10 more cycles (40 fold
increase) in the reverse subtracted Ctls-SH sample.
Differential hybridization screening was performed using
macroarrays in order to isolate genes implicated in heaves
exacerbation from the 950 randomly selected clones. Differentially
Gene Profiling in the Chronic Asthmatic Lungs
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signal intensities observed between the four membranes. The
positive clones had 1) a stronger hybridization signal with the SH-
Ctls probe than with SH probe, 2) a weaker hybridization signal
with the Ctls-SH probe than with the Ctls probe, and 3) a stronger
hybridization signal with the SH-Ctls probe than with the Ctls-SH
probe. Representative differential screening results are illustrated
in Figure 3. Of the 950 cDNA clones screened, 294 were identified
as strongly expressed and were analyzed on agarose gel.
Sequencing performed on single band PCR amplicons generated
a total of 224 clones with adequate sequencing results for BLAST
analysis and Genbank deposition (accession numbers from
GH613643 to GH613840).
The first group contained 167 sequences with known function,
20 of which were redundant. These sequences were further
categorized based on their biological pathways (Table S2, 147
sequences). The second group contained 57 sequences previously
characterized, but with unknown functions; 9 of these sequences
were redundant (Table S2, 48 sequences). In group I, there were
14 genes related to regulatory proteins, 14 to immune signaling
molecules, 13 to intracellular signaling component pathways, 10 to
immune response, 5 to cell growth and proliferation, 5 to free
radical metabolism (Table S2, 61 genes). There were 86 additional
genes with known cell function (6 to transmembrane proteins, 10
to structural proteins, 4 to extracellular proteins, 1 to complement
components, 4 to gene transcription, 2 to cell adhesion molecules,
Figure 2. Evaluation of subtraction efficiency. A: Reduction of GAPDH cDNA following subtraction in the SH-Ctls sample. PCR was performed on
SH-Ctls subtracted and SH unsubtracted samples. GAPDH PCR products (760 pb) were detectable 10 cycles earlier in the unsubtracted sample (18
cycles) than in the subtracted sample (28 cycles). B: Enrichment of LCN2 cDNA following subtraction in the SH-Ctls sample. PCR was performed on SH-
Ctls and Ctls-SH subtracted samples as well as SH and Ctls unsubtracted samples. LCN2 PCR products (210 pb) were detected after 20 cycles for both
SH unsubtracted and SH-Ctls subtracted samples, the difference in the intensity of the 2 bands indicate the enrichment compare to Ctls unsubtracted
and Ctls-SH subtracted samples.
doi:10.1371/journal.pone.0029440.g002
Figure 3. Differential hybridization screening. Representative differential screening results of macroarrays of the SH-Ctls library. Four identical
membranes were dot-blotted with PCR products obtained by SSH. The membranes were then hybridized with four different probes: SH-Ctls
subtracted cDNAs (A), SH unsubtracted cDNAs (B), Ctls-SH subtracted cDNAs (C) and Ctls unsubtracted cDNAs. The arrow in the top left corner
indicates the positive control (LCN2). The arrow head indicates an example of differentially expressed genes in SH compare with Ctls.
doi:10.1371/journal.pone.0029440.g003
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transport proteins, 13 to metabolic enzymes, 4 to proteolytic
enzymes and 5 to protein binding).
Gene expression analysis
To confirm the differential gene expression pattern in heaves-
affected horses, mRNA expression was compared by qPCR in
individual heaves and control horses before and after challenge.
The 22 genes selected for validation were chosen because they had
previously been associated with asthma, or because of their
possible contribution to airway inflammation and remodeling.
They included LCN2, collagen type I alpha 2 (COL1A2), collagen
type III alpha 1 (COL3A1), protein phosphatase 3 catalytic subunit
beta (PPP3CB), glypican 4 (GPC4), versican (VCAN), chemokine (C-
C motif) ligand 5 (CCL5), decorin (DCN), major histocompatibility
complex class II invariant chain CD74 molecule (CD74), dedicator
of cytokinesis 1 (DOCK1), fucosidase alpha-L-1 (FUCA1), mito-
chondrial translational release factor 1-like (MTRF1L), NHL
repeat containing 2 (NHLRC2), prostaglandin D2 receptor
(PTGDR), leukotriene A-4 hydrolase (LTA4H), endothelin receptor
type A (EDNRA), chemokin binding protein 2 (CCBP2), insulin-like
growth factor I (IGF1), gamma actin (ACTG1), vimentin (VIM),
TRPC4 associated protein (TRPC4AP) and Rho GTPase activat-
ing protein 25 (ARHGAP25). LCN2, COL1A2, PPP3CB, VCAN,
DCN, CD74, NHLRC2, IGF1, FUCA1 and LTA4H mRNA were
significantly increased in heaves-affected horses after the challenge
compared to baseline, in contrast to the mRNA expression in
controls, which remained stable during the study. Similarly,
PTGDR and MTRF1L also showed a significant increase in heaves-
affected horses after challenge compared to baseline, but in
addition, the baseline mRNA expression was significantly higher
in the control group compared to the heaves-affected group. The
expression of ARHGAP25 and ACTG1 mRNA were significantly
decreased after challenge compared to baseline in control horses
only. ARHGAP25, EDNRA and ACTG1 were also significantly
different between groups at baseline, control horses having higher
mRNA expression. There were no significant differences between
groups and between time points in each group in COL3A1, GPC4,
CCL5, DOCK1, CCBP2, TRPC4AP and VIM. Figure 4 represents
the mRNA expression using qPCR for six of the genes found to be
upregulated with SSH.
Quantification for genes of interest is expressed as absolute
concentration because all reference genes tested showed significant
(p,0.05) increase in the lung tissue of heaves-affected horses after
the antigen challenge compared to baseline. The reference genes
tested were GAPDH, ubiquitin C (UBC), b-glucuronidase (GUSB),
ß2-microglobulin (B2M), peptidylprolyl isomerase A (PPIA), large
ribosomal protein P0 (RPLP0), and ribosomal protein S9 (RPS9).
Reference gene analysis using dedicated softwares further
confirmed that the stability of these genes was highly dependent
on horses’ clinical status, precluding their use for normalization. In
view of these results, total RNA and reverse transcribe (RT)
reactions were quantified using a spectrophotometer (NanoDrop
ND-1000, NanoDrop products, Wilmington, DE, USA) and used
to normalize cDNA quantity in the PCR reactions [26]. Lastly, to
ensure that unidentified biases were not introduced during sample
analysis, the upregulation of GAPDH, PPIA, LTA4H, PPP3CB and
LCN2 in horses with heaves after antigen stimulation was
confirmed (data not shown) using samples of lung tissues from
the same animals but archived using a different technique of
preservation (RNA later, Ambion, Austin, TX, USA), RNA
extraction (TRIzolH Invitrogen, Carlsbad, CA, USA) and a
different enzyme for RT reactions (AMV, Roche Diagnostics
Corp, Laval, QC, CA).
Discussion
Large-scale expression studies have highlighted complex
interactions occurring between genes and environment in the
central asthmatic airways [27] and allowed the discovery of novel
pathways implicated in the disease inflammatory and remodeling
processes. In the present study, we generated a reciprocal cDNA
library representing mRNA specific to the peripheral lung of
asthmatic horses during exacerbation. This led to the identification
of 195 genes, 75.4% of which corresponded to genes with known
sequences and functions and 24.6% to uncharacterized cDNAs.
Quantitative PCR confirmed the differential gene expression
pattern in 15 of the 22 genes evaluated. The functions of many of
these genes were related to inflammation, remodeling, and smooth
muscle biology, possibly representing new therapeutic targets for
asthma.
Genes associated with remodeling and smooth muscle
contraction
Inflammation and repair of injured lung tissues in asthma results
in an increased thickness of the airway wall leading to reduced
baseline airway caliber and exaggerated airway narrowing,
phenomena that are accentuated in allergen-induced broncho-
spasm [28]. Of particular importance to asthma is the increased
airway smooth muscle (ASM) mass observed in human subjects
(reviewed by [29]) and in equine heaves [14,15]. Not only are
ASM cells increased in number or size and contribute to the
bronchospasm, but they show, at least in vitro, some phenotype
plasticity in response to allergen challenge, including de-differen-
tiation to a more synthetic type capable of producing an
extracellular matrix (ECM), various cytokines, and growth factors
(reviewed by [30]). However, the molecular pathways responsible
for these changes are poorly defined. Herein, we identified at least
13 genes that have been linked to smooth muscle biology. Four
genes (ARHGAP25, phosphatidylinositol transfer protein alpha
(PITPNA), phosphatidylinositol-specific phospholipase C X do-
main containing 3 (PLCXD3), and pyruvate dehydrogenase kinase
isozyme 1 (PDK1)) identified in the lung tissues of heaves-affected
horses in exacerbation are involved in the modulation of the RhoA
pathway [31]. This pathway is necessary for the activation of
factor serum response factor (SRF) by myocardin [32], one of its
coactivators, which leads to the expression of contractile protein
genes expression [33]. Interestingly, RhoA/Rho kinase is required
for ASM contraction induced by endothelin-1 (EDN1) [34] and is
upregulated by interleukin-4 (IL-4), a Th2 cytokine expressed in
the airways of asthmatic patients [35]. Our results are thus in
agreement and extend those of in vitro and animal studies, and
further support the proposal of Rho kinase inhibitors as new
targets for the treatment of airway bronchoconstriction and
remodeling seen in asthma (reviewed by [36]). Conversely, it is the
mitogen-activated protein kinase (MAPK) signaling pathway that
promotes smooth muscle proliferation by modulating SRF-
transcriptional activities via the activation Elk-1 [32,33]. MAPK1
identified in our SSH activates Elk-1 [37], suggesting that both
ASM proliferation and differentiation may coexist in the asthmatic
lungs.
PPP3CB (also known as calcineurin) and IGF1 identified by SSH
share common signaling pathways also possibly contributing to
smooth muscle phenotype switching and ECM remodeling in
asthma [38,39,40,41,42]. The identification of PPP3CB, and one of
its inhibitors, calcineurin homologous protein (CHP) [43], is of
particular interest as PPP3CB/NFAT signaling is implicated in a
wide range of biological responses relevant to asthma including
lymphocyte activation, as well as neuronal and muscle development
Gene Profiling in the Chronic Asthmatic Lungs
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knowledge, PPP3CB activation results in muscle hypertrophy in
response toincreaseworkloadinboththeurinarybladder and inthe
heart [46,47,48]. Furthermore, alterations of the expression of the
fast and slow myosin heavy chain isoforms in the obstructed bladder
is PPP3CB-dependent [48]. Thus the PPP3CB pathway may
participate in the increased ASM mass and the myosin heavy chain
isoform switching observed in the asthmatic airways [49]. The
expression of EDN1, a potent spasmogen for the bronchus, is
increased in asthma [50], and single nucleotide polymorphisms
(SNPs) have been associated with susceptibility to this disease [51].
One of its receptor, EDNRA, identified in our SSH, has previously
been found to be upregulated in this animal model [52].
Interestingly, the PPP3CB/NFAT pathway discussed above has
beenshown to be required for at least someof the effects of EDN1 in
cardiac myocytes [39,53], and thus, are further support for their
possible modulation of ASM remodeling.
IGF1 plays a vital role in embryonic development and promotes
the anabolism and the repair of various tissues in adults [54].
There are several evidences suggesting that IGF1 may also
contribute to asthma. IGF1 is produced by human bronchial
epithelial cells in response to IL-17F [55], a cytokine implicated in
asthma. It was shown to induce the expression of alpha-smooth
muscle actin and type-I collagen by human fetal lung fibroblasts
[56], and to promote visceral myocyte differentiation into a
contractile phenotype via the PPP3CB/NFAT pathway [57,58].
The increased expression of IGF1 in the peripheral lung tissue of
horses with heaves during exacerbation is thus of interest to
asthma, especially in the light that IGF1 neutralizing antibody
inhibits airway obstruction and inflammation, while preventing
airway wall thickening in a mouse model of asthma [59].
There is also alteration of various components of the ECM in
the asthmatic airways. These changes vary depending on size of
airways, and it has been shown that an increase in the degree of
Figure 4. Gene expression analysis. Analysis of mRNA expression using qPCR of six genes found up-regulated with SSH. LCN2 (A), COL1A2 (B),
PP3CB (C), PTGDR (D), LTA4H (E) and IGF1 (F) were studied in six horses with heaves (black bars) and six control horses (white bars). When compared to
baseline, the six genes were significantly increased in heaves-affected horses after the allergen challenge (p,0.05). PTDGR was also increased in
control horses when compared to heaves-affected horses at baseline.
doi:10.1371/journal.pone.0029440.g004
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asthma [60]. Not surprisingly, gene expression of ECM molecules
including collagens (COL1A2, COL3A1), and proteoglycans (DCN,
GPC4, VCAN) were identified by SSH. The expression of
collagen, type I, and type III led us to investigate the total
collagen content in the airways of these horses which revealed to
be increased (unpublished data). The increased expression of the
intermediate filaments VIM may also be relevant as it is required
for epithelial to mesenchymal transition, a phenomenon where
epithelial cell properties change from non-migrational to a
fibroblastic and migrational-mesenchymal cell type, which has
been proposed to be contributing to the increased ASM mass
observed in asthma [61].
Genes associated with inflammation
Pulmonary inflammation is a characteristic finding in asthma
and anti-inflammatory drugs are central for its control. Seven
genes associated with leukotriene (LT)B4 metabolism or prosta-
glandin (PG)D2 activity were identified as being overexpressed in
the lungs of horses with heaves during exacerbation. Those
included LTA4 hydrolase which metabolizes LTA4 in LTB4, PGF
synthase that reduces PGD2 and PGH2 to PGF2, PTGDR (also
named DP1), a PGD2 receptor involved in the regulation of Th2-
type driven inflammation [62], and CNOT7 (CCR4-NOT
transcription complex), a repressor of the retinoid X beta receptor
(Rxrb) [63], which forms a heterodimeric complex with the nuclear
receptors PPARs (peroxisome proliferator-activated receptor).
LTB4 is an arachidonic acid metabolite synthesized by various
cell types when activated by inflammatory stimuli. LTB4 was first
described as a potent chemoattractant and activator of neutro-
phils, the predominant airway cell population present in heaves,
and in some asthmatic patients [64]. It is now recognized that
LTB4 also exerts these effects on other cell types involved in airway
inflammation [65] and it has also been suggested that it is
implicated in T cell trafficking and asthmatic inflammation [66].
Further support for a role of LTB4 in asthma is its increase in
exhaled breath condensate of affected patients [67], and the
attenuation of allergic airway inflammation and hyperresponsive-
ness by LTA4H inhibition [68]. However, the effects of LTA4H are
complex, as it can also limit tissue damage-induced neutrophilia
through its aminopeptidase activity which degrades proline-
glycine-proline (PGP), a collagen breakdown product possessing
potent neutrophil chemotactic activity [69]. PGD2 is also an
arachidonic acid metabolite that is released in large quantities by
mast cells during anaphylaxis. Other cell types present in lung
tissues such has dendritic cells, macrophages, eosinophils, Th2
cells, and endothelial cells may also produce PGD2, and contribute
to asthmatic inflammation [66]. PGD2 exerts its effects by
activating two distinct G protein-coupled receptors, including
the PTGDR identified by SSH. It has been recently proposed that
PTGDR may regulate PGD2-directed T-cell trafficking and Th2-
dependent airway inflammation [62,66]. These results suggest that
the pharmacological modulation of these lipidic mediators
represent possible novel therapeutic targets for the treatment of
human asthma [70].
In summary, we have identified genes and pathways relevant to
the asthmatic inflammation and remodeling that were upregulated
in the peripheral lung tissues of horses with heaves when antigen
challenged. Genes previously associated with asthma as well as
novel pathways were also identified. These genes encompass a
range of biological processes with pathways related to ASM and
ECM remodeling, and inflammation being notable. Our results
suggest that targeting RhoA, PPP3CB, EDN1, and IGF1 signaling
pathways may represent appropriate targets for anti-remodeling
therapies, especially for the control ASM hypertrophy, while anti-
inflammatory effects may possibly be achieved by drugs modulat-
ing LTB4 and PGD2.
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